SCHEMBL6188705

SCHEMBL6188705

COc1ccc2oc(=O)cc(OS(=O)(=O)C(F)(F)F)c2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.55
HPGD P15428 7/20 0.55
KDM4E B2RXH2 5/20 0.55
HSD17B10 Q99714 3/20 0.55
DYRK1A Q13627 1/20 0.50
RAB9A P51151 3/20 0.49
NPC1 O15118 2/20 0.49
MAPT P10636 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
CASP3 P42574 1/20 0.49
SENP8 Q96LD8 1/20 0.49
SENP7 Q9BQF6 1/20 0.49
SENP6 Q9GZR1 1/20 0.49
STS P08842 1/20 0.46
PRKDC P78527 1/20 0.45
KMT2A Q03164 2/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA3 P07451 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3553197 0.90 KDM4E (0.55) ALDH1A1HPGDKDM4EHSD17B10RAB9A
SCHEMBL30231652 0.90 KDM4E (0.55) ALDH1A1HPGDKDM4EHSD17B10RAB9A
SCHEMBL6189563 0.85 ALDH1A1 (0.43) ALDH1A1HPGDKDM4EHSD17B10DYRK1A
SCHEMBL17844932 0.83 TNKS (0.40) ALDH1A1KDM4ESTSKMT2ACA12
SCHEMBL6186298 0.82 PIM1 (0.49) ALDH1A1KDM4ESTSKMT2ACA12
SCHEMBL6188377 0.82 PRKDC (0.41) ALDH1A1DYRK1ASTSPRKDCCA1
SCHEMBL12365881 0.81 AR (0.42) ALDH1A1HPGDKDM4EHSD17B10RAB9A
SCHEMBL15842463 0.80 KDM4E (0.71) ALDH1A1HPGDKDM4EHSD17B10DYRK1A
SCHEMBL1358175 0.80 STS (0.71) ALDH1A1HPGDKDM4EHSD17B10STS
SCHEMBL18117616 0.80 MAOA (0.48) ALDH1A1HPGDKDM4EHSD17B10RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6921821-B2 Antagonists of melanin concentrating hormone receptor ABBOTT LABORATORIES (US) 2005-07-26 US disclosed
EP-1534703-A2 ANTAGONISTS OF MELANIN CONCENTRATING HORMONE RECEPTOR ABBOTT LABORATORIES (US) 2005-06-01 EP disclosed
US-20040106645-A1 Antagonists of melanin concentrating hormone receptor MILLENNIUM PHARMACEUTICALS, INC. 2004-06-03 US disclosed
WO-2003106452-A2 ANTAGONISTS OF MELANIN CONCENTRATING HORMONE RECEPTOR MILLENNIUM PHARMACEUTICALS, INC. (US) 2003-12-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040106645-A1 Antagonists of melanin concentrating hormone receptor MCHR1, MCHR2, MC1R ALDH1A1 660/4885HPGD 1048/4885KDM4E 1548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.